Compex Use With Delayed Onset Muscle Soreness: A Comparison to Other Methods
NCT ID: NCT01967121
Last Updated: 2014-08-29
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2013-10-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Individuals will then be assigned to a modality of either ice, control group or compex. Individuals will perform the modality (ice, control, compex) we assign you to until you are no longer sore.
Over the next five days individuals will return to measure their level of soreness, leg girth and pain pressure.
This study will examine the following hypotheses:
H1: There will be no difference in pressure pain threshold after using the Compex compared to other groups.
H2: There will be no difference in perceived soreness after using the Compex compared to other groups.
H3: There will be no difference in muscular strength after using the Compex compared to other groups.
H4: There will be no difference in active range of motion after using the Compex compared to other groups.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
'Compex unit's Active Recovery® program'
The Compex electrical stimulation system utilized in this study is intended for external application with electrodes to create a muscular contraction and help enhance recovery after eccentric muscular activity.
Compex unit's Active Recovery® program
Compex unit's Active Recovery® program will be performed for 15 minutes once per day.
Ice application
A randomized pre and post-test research design will be used to compare three interventions (control, ice, compex) to alleviate the physical symptoms of delayed-onset muscle soreness (DOMS).
Ice application
Participants will apply ice on their hamstring for 15 minutes three times per day until muscle soreness is no longer present
Control
This is a control group where subjects will not perform an intervention.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Compex unit's Active Recovery® program
Compex unit's Active Recovery® program will be performed for 15 minutes once per day.
Ice application
Participants will apply ice on their hamstring for 15 minutes three times per day until muscle soreness is no longer present
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Inclusionary criteria will be participation in a physical activity as defined by the ACSM, which can be a mixture of moderate (i.e., sufficient to raise the heart rate and begin to sweat) and vigorous (i.e., breathing hard and fast with a rapidly rising heart rate) intensity aerobic activity and muscle strengthening (i.e., weights lifted to the point where anther repetition cannot be completed without help) activities two or more time per week (ACSM, 2011.)
Exclusion Criteria
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Michigan State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tracey Covassin
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tracey Covassin, PhD
Role: PRINCIPAL_INVESTIGATOR
Michigan State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Michigan State University
East Lansing, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB# 13-849F
Identifier Type: -
Identifier Source: org_study_id